1. Home
  2. CTOR vs ASMB Comparison

CTOR vs ASMB Comparison

Compare CTOR & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTOR
  • ASMB
  • Stock Information
  • Founded
  • CTOR 2021
  • ASMB 2005
  • Country
  • CTOR United States
  • ASMB United States
  • Employees
  • CTOR N/A
  • ASMB N/A
  • Industry
  • CTOR
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTOR
  • ASMB Health Care
  • Exchange
  • CTOR NYSE
  • ASMB Nasdaq
  • Market Cap
  • CTOR 89.9M
  • ASMB 84.5M
  • IPO Year
  • CTOR N/A
  • ASMB 2010
  • Fundamental
  • Price
  • CTOR $1.23
  • ASMB $12.57
  • Analyst Decision
  • CTOR Strong Buy
  • ASMB Buy
  • Analyst Count
  • CTOR 2
  • ASMB 2
  • Target Price
  • CTOR $4.50
  • ASMB $35.00
  • AVG Volume (30 Days)
  • CTOR 78.9K
  • ASMB 21.7K
  • Earning Date
  • CTOR 02-21-2025
  • ASMB 03-27-2025
  • Dividend Yield
  • CTOR N/A
  • ASMB N/A
  • EPS Growth
  • CTOR N/A
  • ASMB N/A
  • EPS
  • CTOR N/A
  • ASMB N/A
  • Revenue
  • CTOR N/A
  • ASMB $28,326,000.00
  • Revenue This Year
  • CTOR N/A
  • ASMB $282.16
  • Revenue Next Year
  • CTOR N/A
  • ASMB N/A
  • P/E Ratio
  • CTOR N/A
  • ASMB N/A
  • Revenue Growth
  • CTOR N/A
  • ASMB N/A
  • 52 Week Low
  • CTOR $0.85
  • ASMB $11.01
  • 52 Week High
  • CTOR $49.00
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • CTOR N/A
  • ASMB 34.21
  • Support Level
  • CTOR N/A
  • ASMB $13.60
  • Resistance Level
  • CTOR N/A
  • ASMB $14.25
  • Average True Range (ATR)
  • CTOR 0.00
  • ASMB 0.57
  • MACD
  • CTOR 0.00
  • ASMB -0.11
  • Stochastic Oscillator
  • CTOR 0.00
  • ASMB 3.02

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: